LUMOS PHARMA, INC. Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Lumos Pharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Lumos Pharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 5, 2024 was 8.65M shares, a 9.27% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.65M +734K +9.27% Nov 5, 2024 10-Q 2024-11-07
Q2 2024 8.12M +189K +2.38% Jul 26, 2024 10-Q 2024-08-02
Q1 2024 8.11M -112K -1.37% Mar 1, 2024 10-K/A 2024-04-22
Q3 2023 7.91M -462K -5.51% Nov 2, 2023 10-Q 2023-11-07
Q2 2023 7.94M -446K -5.32% Aug 7, 2023 10-Q 2023-08-10
Q1 2023 8.22M -139K -1.67% Mar 3, 2023 10-K 2023-03-07
Q3 2022 8.38M +18.8K +0.23% Nov 4, 2022 10-Q 2022-11-14
Q2 2022 8.38M +24.3K +0.29% Aug 3, 2022 10-Q 2022-08-10
Q1 2022 8.36M +33K +0.4% Mar 4, 2022 10-K 2022-03-11
Q3 2021 8.36M +60.3K +0.73% Nov 1, 2021 10-Q 2021-11-05
Q2 2021 8.36M +64.6K +0.78% Aug 3, 2021 10-Q 2021-08-06
Q1 2021 8.33M -29M -77.7% Mar 5, 2021 10-K 2021-03-09
Q3 2020 8.3M -29M -77.8% Nov 6, 2020 10-Q 2020-11-12
Q2 2020 8.29M -29M -77.8% May 27, 2020 10-Q 2020-06-02
Q1 2020 37.3M +52.3K +0.14% Feb 25, 2020 10-K 2020-03-03
Q3 2019 37.3M +89.5K +0.24% Oct 31, 2019 10-Q 2019-11-06
Q2 2019 37.3M +98.3K +0.26% Aug 6, 2019 10-Q 2019-08-08
Q1 2019 37.3M +120K +0.32% Feb 27, 2019 10-K 2019-03-05
Q3 2018 37.2M +147K +0.4% Oct 30, 2018 10-Q 2018-11-02
Q2 2018 37.2M +7.79M +26.5% Aug 1, 2018 10-Q 2018-08-06
Q1 2018 37.2M +7.94M +27.2% Mar 2, 2018 10-K 2018-03-05
Q3 2017 37.1M +7.94M +27.3% Oct 31, 2017 10-Q 2017-11-03
Q2 2017 29.4M +452K +1.56% Aug 1, 2017 10-Q 2017-08-03
Q1 2017 29.2M +355K +1.23% Feb 28, 2017 10-K 2017-03-06
Q3 2016 29.1M +349K +1.21% Nov 2, 2016 10-Q 2016-11-08
Q2 2016 29M +251K +0.87% Aug 2, 2016 10-Q 2016-08-05
Q1 2016 28.9M +383K +1.34% Apr 26, 2016 10-Q 2016-04-29
Q3 2015 28.8M +826K +2.95% Nov 3, 2015 10-Q 2015-11-06
Q2 2015 28.7M +809K +2.9% Jul 29, 2015 10-Q 2015-08-06
Q1 2015 28.5M +617K +2.22% Mar 10, 2015 10-K 2015-03-16
Q3 2014 28M +2.25M +8.77% Nov 6, 2014 10-Q 2014-11-10
Q2 2014 27.9M +2.21M +8.59% Jul 31, 2014 10-Q 2014-08-05
Q1 2014 27.9M +2.26M +8.82% Mar 7, 2014 10-K 2014-03-12
Q3 2013 25.7M +4.79M +22.9% Nov 5, 2013 10-Q 2013-11-12
Q2 2013 25.7M +4.8M +23% Aug 5, 2013 10-Q 2013-08-08
Q1 2013 25.6M +4.93M +23.9% Mar 12, 2013 10-K 2013-03-15
Q3 2012 20.9M Oct 24, 2012 10-Q 2012-10-31
Q2 2012 20.9M Aug 10, 2012 10-Q 2012-08-14
Q1 2012 20.7M May 4, 2012 10-Q 2012-05-10
Q4 2011 20.7M Dec 31, 2011 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.